Jazz Pharma's Ziihera Gets USFDA Nod To Treat HER2-Positive Biliary Tract Cancer Farhat Nasim22 Nov 2024 12:30 PM ISTThe drug zanidatamab-hrii, sold under the brand name Ziihera, is approved for use in previously treated adults with metastatic HER2-positive biliary...
AstraZeneca gets a CDSCO panel Nod To study Rilvegostomig Dr. Divya Colin11 Dec 2023 6:00 PM ISTNew Delhi: The drug major AstraZeneca has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
AstraZeneca Imfinzi plus chemotherapy approved in China for locally advanced or metastatic biliary tract cancer Ruchika Sharma19 Nov 2023 11:45 AM ISTImfinzi (durvalumab) is a human monoclonal antibody that binds to the PD-L1 protein and blocks the interaction of PD-L1 with the PD-1 and CD80...
Merck bags USFDA nod for Keytruda plus gemcitabine, cisplatin to treat Biliary Tract Cancer Ruchika Sharma2 Nov 2023 2:30 PM ISTKEYTRUDA is an anti-programmed death receptor-1 (PD-1) therapy that works by increasing the ability of the body's immune system to help detect and...
USFDA accepts application for Merck KEYTRUDA plus chemotherapy as treatment for Biliary Tract Cancer Ruchika Sharma9 Jun 2023 5:30 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced the U.S. Food and Drug Administration (FDA) has accepted for review...
AstraZeneca India gets CDSCO nod for Durvalumab to treat biliary tract cancer Ruchika Sharma17 Feb 2023 12:00 PM ISTNew Delhi: Science-led biopharmaceutical company, AstraZeneca India, has announced additional indication approval from Central Drugs...
Medical Bulletin 23/January/2023 Isra Zaman23 Jan 2023 2:30 PM ISTHere are the top medical news for the day:Modified bacteria to tackle drug-resistant lung infectionsResearchers have designed the first ‘living...
Nab-paclitaxel does not extend survival in biliary tract cancer; though has benefits for some Isra Zaman23 Jan 2023 9:15 AM ISTAdding nab-paclitaxel to a standard treatment of gemcitabine plus cisplatin does not significantly extend median overall survival (OS) time for...
AstraZeneca gets Japanese approval for Imfinzi, Imjudo to treat 3 types of cancer Ruchika Sharma28 Dec 2022 11:30 AM ISTImfinzi (durvalumab) is a human monoclonal antibody that binds to the PD-L1 protein and blocks the interaction of PD-L1 with the PD-1 and CD80...
AstraZeneca gets USFDA nod for Imfinzi plus chemotherapy to treat advanced biliary tract cancer Ruchika Sharma5 Sept 2022 1:30 PM ISTBiliary tract cancer is a group of rare and aggressive cancers that occur in the bile ducts and gallbladder.
Durvalumab plus Gemcitabine and Cisplatin in Advanced Biliary Tract Cancer: study Dr. Shravani Dali7 July 2022 8:00 PM ISTDurvalumab plus Gemcitabine and Cisplatin in Advanced Biliary Tract Cancer, according to a recent study published in the NEJM Evidence Patients...
Gallium 68-labeled FAPI-PET promising for biliary tract cancer detection: Study Medha Baranwal25 May 2022 6:00 AM ISTChina: Gallium 68-labeled fibroblast-activation protein inhibitor (FAPI)-PET imaging is superior to current methods for more accurate staging of...
